Investigating chelating sulfonamides and their use in metalloproteinase inhibitors - Wikidata - wikimedia - TriplyDB

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

http://www.wikidata.org/entity/Q34192481

about

Metal complexes and metalloproteases: targeting conformational diseases.Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies.3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators.HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.Inhibition of matrix metalloproteinases and toxicity of gold and platinum nanoparticles in L929 fibroblast cells.Gold Nanoparticles Inhibit Matrix Metalloproteases without Cytotoxicity.Matrix metalloproteases inhibition and biocompatibility of gold and platinum nanoparticles.

P2860

Q38215608-ED5210ED-B919-459F-B0F5-1D74F25D007F Q39249230-FE735AF5-2F50-40AB-8C8F-4EC5C5DB1563 Q41950065-BEE7D855-1FB9-4563-A630-B660AACFBCCB Q49874343-8B5E8759-0D2C-4214-836A-59EA8504131B Q51585312-49867BA0-3680-4FE6-874F-1A9F526C6D0E Q52939052-4E00A7F9-1ED5-4E01-AE27-226C44F72636 Q53376357-2C6ADE61-EB83-4540-A99C-A74550ABE5CC

P2860

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

http://www.wikidata.org/entity/Q34192481

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@ast

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@en

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@nl

type

label

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@ast

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@en

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@nl

prefLabel

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@ast

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@en

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@nl

P1433

Q34192481-7DEE920E-2BB8-4BB0-B63C-A04226D53511

P1476

Q34192481-DB447A81-AA7F-4220-95EF-9227A82BBC10

P2093

Q34192481-8501CB9C-76A6-4D4A-B156-BA98DC0464FB

Q34192481-86A301C3-F3BA-4EE6-BF89-8C0ED9B8E954

Q34192481-ADD28619-BFAA-47DE-A710-74E4249E2FC7

P2860

Q34192481-19FA8A8A-041C-4C2B-B03E-C13C01512000

Q34192481-3096320C-0D27-4DC4-93B8-F8B2BEAC07F6

Q34192481-3F7F62AB-5C63-4945-8CA5-8770B20AD265

Q34192481-4BD183A9-62D7-474B-9307-A882867A00CE

Q34192481-534EDFC6-AF89-44BC-8486-AA5349BCC220

Q34192481-54CD70BE-3B08-4106-9919-B5A8D8E10618

Q34192481-5F7E474A-5BB9-4793-9F57-DD6F977E4B04

Q34192481-698B08D7-860E-438C-8E1A-7F749806DEC5

Q34192481-7415C14A-EA19-4272-B8AC-5A0C1F25FCC8

Q34192481-7B732E10-B3A4-4236-B593-C25683536382

P304

Q34192481-D5A88A1A-1C74-4DC7-877A-D0A2488BD824

P31

Q34192481-D3365E42-ADA9-467C-B3B8-8BC929412973

P356

Q34192481-0DCD67F3-59F8-4068-BAAD-AF30A390E482

P407

Q34192481-CA536643-5B43-4815-AFE0-0A52B6405766

P433

Q34192481-EE99220D-805B-4627-8914-EED005BCB0F9

P478

Q34192481-4F6974AA-2934-4F11-9F6B-3455F1D4E691

P50

Q34192481-F29D4DFF-2E58-4475-9B3E-683ABE61FAFF

P577

Q34192481-947250F8-E288-46D0-96E5-C1CAF92AA76D

P698

Q34192481-146F4D1D-2C13-404E-9E34-B144875AAB79

P932

Q34192481-0379C654-D7F8-42EC-9E67-9EAF8880B4BC

P356

P1433

Dalton Transactions

P1476

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

@en

P2093

Alisa Tanakit

http://www.w3.org/2001/XMLSchema#string

David P Martin

http://www.w3.org/2001/XMLSchema#string

Matthieu Rouffet

http://www.w3.org/2001/XMLSchema#string

P2860

Design and therapeutic application of matrix metalloproteinase inhibitors

In situ imaging of metals in cells and tissues

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.

Excited-state intramolecular proton transfer in 2-(2'-arylsulfonamidophenyl)benzimidazole derivatives: the effect of donor and acceptor substituents.

Synthetic active site-directed inhibitors of metzincins: achievement and perspectives.

Human DNA polymerase alpha uses a combination of positive and negative selectivity to polymerize purine dNTPs with high fidelity

Insight into the structural determinants for selective inhibition of matrix metalloproteinases.

MMP induction and inhibition in myocardial infarction.

Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies.

P304

6507-6515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C2DT12373H

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22411188

http://www.w3.org/2001/XMLSchema#string

P932

3685695

http://www.w3.org/2001/XMLSchema#string